The genes NDRG1 [25] and SREBF2 [27] have also been reported as potential prognostic biomarkers for RCC, and SREBF1/2 were found to play roles in regulating lipid metabolism and have effects on ccRCC growth and survival. The gene discussed is SREBF1; the disease is renal cell adenocarcinoma.